Cargando…

Is estrogen receptor negative breast cancer risk associated with a fast life history strategy?

Detalles Bibliográficos
Autores principales:	Hidaka, Brandon H., Boddy, Amy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716563/ https://www.ncbi.nlm.nih.gov/pubmed/26781544 http://dx.doi.org/10.1093/emph/eov034

Ejemplares similares

Life history theory and breast cancer risk: methodological and theoretical challenges: Response to “Is estrogen receptor negative breast cancer risk associated with a fast life history strategy?”
por: Aktipis, Athena
Publicado: (2016)

Early life adversity, reproductive history and breast cancer risk
por: Boddy, Amy M, et al.
Publicado: (2022)

Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers
por: Wang, Qiao-Li, et al.
Publicado: (2023)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
por: Batra, Atul, et al.
Publicado: (2020)

Reply to Letter to Editor: “HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?”
por: Li, Shuai, et al.
Publicado: (2020)

Procrastination as a Fast Life History Strategy
por: Chen, Bin-Bin, et al.
Publicado: (2016)

The Life History of Ascaris Lumbricoides
por: Lane, Clayton
Publicado: (1917)

The Life History of Ascaris Lumbricoides
por: Stewart, F. H.
Publicado: (1917)

Exploiting the mechanism of estrogen-induced transcription to fight breast cancer
por: Perillo, Bruno, et al.
Publicado: (2021)

Coffee consumption modifies risk of estrogen-receptor negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2011)

Distribution and Life History of Dochmius Duodenalis
por: Giles, J. M.
Publicado: (1896)

Unopposed estrogen and endometrial cancer: association or causation?
por: LaCroix, Andrea, et al.
Publicado: (2019)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia
por: Morelli, Eugenio, et al.
Publicado: (2022)

The prevalence of estrogen receptor-negative breast cancer in Ethiopia
por: Kantelhardt, Eva Johanna, et al.
Publicado: (2014)

Comment on “Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts”
por: Chevalier, Nicolas, et al.
Publicado: (2016)

Peri-implant osteonecrosis of the jaw in a patient prescribed selective estrogen receptor modulators
por: Yoshino, Tona, et al.
Publicado: (2023)

Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Response to “Comment on ‘Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts’”
por: Lappano, Rosamaria, et al.
Publicado: (2016)

Life History Trade-Offs in Tumors
por: Boddy, Amy M., et al.
Publicado: (2018)

A genome-wide association scan on estrogen receptor-negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2010)

Childhood environmental harshness and unpredictability negatively predict eHealth literacy through fast life-history strategy
por: Feng, Wenfei, et al.
Publicado: (2023)

Quantification of angiogenesis in estrogen receptor-positive and negative breast carcinoma
por: Parentes-Vieira, JB, et al.
Publicado: (2007)

Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
por: Litzenburger, Beate C., et al.
Publicado: (2014)

PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer
por: Glazer, Robert I., et al.
Publicado: (2017)

Retraction: G-Protein–Coupled Receptor 30 and Estrogen Receptor-α Are Involved in the Proliferative Effects Induced by Atrazine in Ovarian Cancer Cells
Publicado: (2014)

Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
por: Hu, Shuying, et al.
Publicado: (2022)

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
por: Jumppanen, Mervi, et al.
Publicado: (2007)

Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility
por: Aktipis, C. Athena, et al.
Publicado: (2014)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Estrogen and cerebral small vessel disease
por: Gao, Hui, et al.
Publicado: (2021)

Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer
por: Gao, Guimin, et al.
Publicado: (2017)

Family history & the risk for adult onset asthma
por: Davoodi, Parisa, et al.
Publicado: (2015)

Promoter Hypermethylation of Estrogen Receptor Alpha Gene Is Correlated to Estrogen Receptor Negativity in Iranian Patients with Sporadic Breast Cancer
por: Izadi, Pantea, et al.
Publicado: (2012)

Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer
por: Vallega, Karin A., et al.
Publicado: (2016)

Putative Biomarkers and Targets of Estrogen Receptor Negative Human Breast Cancer
por: Sahab, Ziad J., et al.
Publicado: (2011)

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a3ghl4gb0mf84ep54oo3blb97f